The Fort Worth Press - US greenlights pig kidney transplant trials

USD -
AED 3.672504
AFN 63.000105
ALL 81.708441
AMD 368.691786
ANG 1.790403
AOA 917.500883
ARS 1429.508702
AUD 1.415508
AWG 1.8025
AZN 1.696166
BAM 1.685177
BBD 2.015096
BDT 122.817901
BGN 1.69088
BHD 0.377305
BIF 2994.054799
BMD 1
BND 1.281762
BOB 6.938712
BRL 5.059302
BSD 1.000526
BTN 94.560525
BWP 13.406112
BYN 2.76997
BYR 19600
BZD 2.012252
CAD 1.40145
CDF 2320.999695
CHF 0.79551
CLF 0.022636
CLP 891.019667
CNY 6.76055
CNH 6.757905
COP 3491.5
CRC 455.716489
CUC 1
CUP 26.5
CVE 95.00853
CZK 20.82745
DJF 178.168001
DKK 6.446935
DOP 58.694285
DZD 132.878995
EGP 50.179896
ERN 15
ETB 161.303992
EUR 0.862498
FJD 2.21395
FKP 0.744874
GBP 0.745775
GEL 2.645026
GGP 0.744874
GHS 11.255482
GIP 0.744874
GMD 72.514434
GNF 8763.721587
GTQ 7.626359
GYD 209.290102
HKD 7.833435
HNL 26.754265
HRK 6.495301
HTG 130.666299
HUF 301.458501
IDR 17723
ILS 2.91185
IMP 0.744874
INR 94.5141
IQD 1310.701361
IRR 1375752.498518
ISK 124.550101
JEP 0.744874
JMD 158.238482
JOD 0.709044
JPY 160.370496
KES 129.420474
KGS 87.450279
KHR 4017.784058
KMF 424.999929
KPW 900.00035
KRW 1508.509782
KWD 0.30835
KYD 0.8338
KZT 487.920041
LAK 22016.388216
LBP 89596.067517
LKR 335.185855
LRD 182.097037
LSL 16.148994
LTL 2.95274
LVL 0.60489
LYD 6.374399
MAD 9.250461
MDL 17.459223
MGA 4157.368235
MKD 53.150489
MMK 2099.401411
MNT 3576.563972
MOP 8.072446
MRU 39.93262
MUR 47.240234
MVR 15.449995
MWK 1734.893459
MXN 17.202655
MYR 4.068105
MZN 63.910263
NAD 16.148855
NGN 1358.20232
NIO 36.817798
NOK 9.527085
NPR 151.295881
NZD 1.71681
OMR 0.384503
PAB 1.000526
PEN 3.408382
PGK 4.383153
PHP 60.309034
PKR 278.370642
PLN 3.65949
PYG 6105.515298
QAR 3.657654
RON 4.512297
RSD 101.210472
RUB 72.178713
RWF 1483.728104
SAR 3.752094
SBD 8.065041
SCR 13.834905
SDG 600.501759
SEK 9.39849
SGD 1.28225
SHP 0.746601
SLE 24.750378
SLL 20969.503664
SOS 571.773221
SRD 37.518027
STD 20697.981008
STN 21.109953
SVC 8.754244
SYP 110.532098
SZL 16.145959
THB 32.509815
TJS 9.274765
TMT 3.5
TND 2.928683
TOP 2.40776
TRY 46.299296
TTD 6.796543
TWD 31.512396
TZS 2620.003012
UAH 44.808889
UGX 3701.565583
UYU 40.393596
UZS 12016.40559
VES 591.77565
VND 26300
VUV 118.866954
WST 2.741216
XAF 565.192704
XAG 0.01415
XAU 0.00023
XCD 2.70255
XCG 1.803205
XDR 0.703697
XOF 565.197574
XPF 102.758965
YER 238.601218
ZAR 16.18979
ZMK 9001.202842
ZMW 17.684109
ZWL 321.999592
  • BCC

    1.4100

    72.995

    +1.93%

  • RIO

    0.6650

    106.555

    +0.62%

  • BCE

    -0.1450

    23.905

    -0.61%

  • JRI

    0.1135

    12.78

    +0.89%

  • RELX

    0.3100

    33.15

    +0.94%

  • GSK

    0.1900

    52.41

    +0.36%

  • RYCEF

    1.0700

    18.11

    +5.91%

  • CMSD

    0.0600

    22.32

    +0.27%

  • NGG

    0.1100

    81.68

    +0.13%

  • BP

    -0.3100

    41.28

    -0.75%

  • CMSC

    0.1500

    22.49

    +0.67%

  • VOD

    0.0750

    15.075

    +0.5%

  • AZN

    0.4400

    177.78

    +0.25%

  • RBGPF

    2.1500

    62.87

    +3.42%

  • BTI

    0.4300

    61.49

    +0.7%

US greenlights pig kidney transplant trials
US greenlights pig kidney transplant trials / Photo: © AFP/File

US greenlights pig kidney transplant trials

Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.

Text size:

United Therapeutics along with another company, eGenesis, have been working since 2021 on experiments implanting pig kidneys into humans: initially brain-dead patients and more recently living recipients.

Advocates hope the approach will help address the severe organ shortage. More than 100,000 people in the United States are awaiting transplants, including over 90,000 in need of kidneys.

United Therapeutics's approval, announced Monday, allows the company to advance its technology toward a licensed product if the trial succeeds.

The study authorization was hailed as a "significant step forward in our relentless mission to expand the availability of transplantable organs," by Leigh Peterson, the company's executive vice president.

The trial will initially enroll six patients with end-stage renal disease before expanding to as many as 50, United Therapeutics said in a statement. The first transplant is expected in mid-2025.

Meanwhile, rival eGenesis said it had received FDA approval in December for a separate three-patient kidney study.

"The study will evaluate patients with kidney failure who are listed for a transplant but who face a low probability of receiving a deceased donor offer within a five-year timeframe," the company said.

Xenotransplantation -- transplanting organs from one species to another -- has been a tantalizing yet elusive goal for science.

Early experiments in primates faltered, but advances in gene editing and immune system management have brought the field closer to reality.

Pigs have emerged as ideal donors: they grow quickly, produce large litters, and are already part of the human food supply.

United Therapeutics said trial patients would be monitored for life, assessing survival rates, kidney function, and the risk of zoonotic infections -- diseases that jump from animals to humans.

Currently, there is only one living human recipient of a pig organ: Towana Looney, a 53-year-old from Alabama who received a United Therapeutics kidney on November 25, 2024.

She is also the longest-surviving recipient, having lived with a pig kidney for 71 days as of Tuesday. David Bennett of Maryland received a pig heart in 2022 and survived 60 days.

D.Ford--TFWP